Generics - Sanofi, Cardio-vascular

Filter

Current filters:

SanofiCardio-vascular

Popular Filters

Watson gets FDA approval for generic Sanctura XR and Avapro

14-10-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has received approval from the US Food and Drug…

AllerganAvaproCardio-vascularGenericsGenito-urinaryNorth AmericaRegulationSanctura XRSanofiWatson Pharmaceuticals

Teva launches generic Aprovel in UK

30-08-2012

The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

Bristol-Myers anticipates significant decline in US clopidogrel sales as patent lapses

17-05-2012

GenericsWeb, a patent analysis and search company, recently published an article based on its proprietary…

Bristol-Myers SquibbCardio-vascularClopidogrelGenericsPatentsPharmaceuticalPlavixSanofi

Watson settles over Exalgo; gets favorable news on enoxaparin

29-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

Cardio-vascularEnoxaparin Sodium InjectionExalgoGenericsLegalLovenoxMallinckrodtMomenta PharmaceuticalsNeurologicalNorth AmericaSanofiWatson Pharmaceuticals

Parexel

Parexel

Back to top